Mostrando ítems 1-18 de 18

      Financiación
      T.I.L.L. Photonics (Germany) [1]
      Telethon-Italy [grant number GGP09134] [1]
      The Molecular Genome Analysis Department is supported by the BMBF [1]
      This article contributes to COST Action CA17116 “International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches (SPRINT)”, supported by COST (European Cooperation in Science and Technology). [1]
      This research was funded by Consejería de Economía, Innovación, Ciencia y Empleo (Junta de Andalucía, Spain), grant number AGR-6235. [1]
      This study was supported by grants from the “Ministerio de Ciencia e Innovación” (BFU2009-07671) and from “Fundación Lucha contra la Ceguera” (FUNDALUCE-2008) to JMF, as well as from “Ministerio de Ciencia e Innovación” (BFU2007-61659), from “Junta de Andalucia” (P07-CVI-03008), and from “University of Granada” (2011 GREIB incentive) to MAC. [1]
      This work has been supported by grants SAF 2003-01217, RNIHG c03/02, PI050972, SAF2006-01089 and FIS G03/152 to FJO, grants CICYT SAF:2001–3533 and SAF2004-00889 to JMRdA; grant FIS c03/02 to RQP. [1]
      This work was funded by grants A1-CTS- 324-UGR18 from FEDER-Junta de Andalucía and PP2022.PP.29 from UGR Research Program, Spain. [1]
      This work was supported by grants from Ministerio de Economía y Competitividad, Spain (BFU2010-19981) and Junta de Andalucía, Spain (P07-CVI-03008). [1]
      This work was supported by Junta de Andalucía, Spain, Grant P07-CVI-03008 (http://www.juntadeandalucia.es/organismo​s/economiainnovacioncienciayempleo.html), and Ministerio de Economía y Competitividad, Spain, Grant BFU2010-19981 (http://www.mineco.gob.es/portal/site/min​eco/idi). [1]
      This work was supported by Ministerio de Ciencia e Innovación (SAF2006-01094 and SAF2009-13281-C02-01), Fundación La Caixa (BM06-219-0) and Junta de Andalucía (P07-CTS-0239) to FJO; RTICC (RD06/0020/0068) to ALR. [1]
      This work was supported by operating grants from FightSMA, The SMA Foundation, The Canadian Gene Cure Foundation, CIHR and Families of SMA to A.M. [1]
      This work was supported by the Consejería de Economía, Innovación y Ciencia, Junta de Andalucía (Grant CTS-6183, Proyectos de Investigación de Excelencia 2010 to C.R.-R.) and the Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spain (Grants PS09/00339 and PI12/01085 to E.G.O.). E.L.-D. was supported by fellowships from the Ministerio de Educación y Ciencia, Spain and the University of Granada. [1]
      This work was supported by the Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo (Grant PI060712 to C.R.-R.). J.C.M. was supported by a fellowship from the Ministerio de Educación y Ciencia. [1]
      This work was supported by the Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016, ISCIII Subdirección General de Evaluación y Fomento de la Investigación, Ministerio de Economía y Competitividad, Spain (Grant PI16/01642); the European Regional Development Fund (ERDF/634 FEDER funding); and the Plan Propio, Universidad de Granada (Grant PP2021.PP-12). [1]
      This work was supported by the Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016, ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, Ministerio de Economía y Competitividad, Spain (Grant PI16/01642), by ERDF/FEDER funding, European Community, by the basic sciences program of the Fondo Nacional para el financiamiento de la Ciencia, la Tecnología y la Innovación Francisco José de Caldas (COLCIENCIAS), and by Cal 658-2014, Basic Sciences Program, Colombia. [1]
      This work was supported by the Plan Estatal de Investigación Científica y Técnica y de Innovación 2013–2016, ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, Ministerio de Economía y Competitividad, Spain (Grant PI16/01642), by ERDF/FEDER Funds, European Community and by the Cátedra de Investigación Antonio Chamorro–Alejandro Otero, Universidad de Granada (CACH2017-1). This article contributes to the COST Action CA17116 ‘International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches (SPRINT)’, supported by COST (European Cooperation in Science and Technology). [1]
      This work was supported by Universidad de Granada, Plan Propio 2015;#P3B: FAM, VMC (http://investigacion.ugr.es/pages/planpropio/2015/ resoluciones/p3b_def_28072015); Universidad de Granada CEI BioTic;#CAEP2-84: VMC (http:// biotic.ugr.es/pages/resolucionprovisional enseaanzapractica22demayo/!); and Canadian nstitutes of Health Research;#231421, #318176, #361847: STB, ECL, RK (http://www.cihr-irsc.gc. ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. [1]